Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $10.8 Million - $20 Million
-85,177 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $66.1 Million - $108 Million
-292,719 Reduced 77.46%
85,177 $21.6 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $83.2 Million - $182 Million
-375,034 Reduced 49.81%
377,896 $145 Million
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $49.8 Million - $90 Million
383,167 Added 103.63%
752,930 $177 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $40.4 Million - $68.8 Million
369,763 New
369,763 $48.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Axiom Investors LLC Portfolio

Follow Axiom Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investors LLC with notifications on news.